Skip to content

Author

Pranabandhu Das

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Comparative Evaluation of Concurrent Carboplatin-Paclitaxel Versus Cisplatin-Etoposide Chemoradiotherapy in Unresectable Non-small Cell Lung Cancer: A Prospective Randomized Study

Background: Concurrent chemoradiotherapy (CCRT) is the standard treatment for patients with unresectable non-small cell lung cancer (NSCLC). Cisplatin-etoposide (EP) and weekly carboplatin-paclitaxel (PC) are commonly used concurrent regimens, but comparative data on efficacy and toxicity remain limited. This study com...

Yamini R. Kumar, B. Subramanian, G. V. Deepthi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.